-
N1-Methyl-Pseudouridine-5'-Triphosphate in mRNA Assays
2026-09-04
N1-Methyl-Pseudouridine-5'-Triphosphate links nucleotide chemistry to RNA stability, translation, and vaccine assay design. This article develops a practical framework for using N1-Methylpseudo-UTP in modified RNA workflows, with insights from a recent influenza mRNA–LNP study.
-
Icatibant in Viral Infections: Evidence and Limits
2026-09-04
The reference letter frames icatibant as both a potential treatment and a mechanistic probe for bradykinin-mediated vascular leakage in hantavirus disease and COVID-19. Its main contribution is a clinically grounded rationale for early, controlled evaluation, while the limited case-report evidence does not establish efficacy or a transferable dosing regimen.
-
Epinephrine Bitartrate Research Workflows
2026-09-03
Epinephrine Bitartrate enables controlled activation of α- and β-adrenergic receptors across cell, cardiovascular, and neurobiology assays. This guide translates receptor pharmacology and local-anesthesia evidence into practical concentration selection, workflow design, and troubleshooting strategies.
-
Recombinant Mouse IFN-γ in MASH-HCC Research
2026-09-02
A translational framework for using Recombinant Mouse IFN-γ to distinguish reversible antigen-presentation defects from deeper metabolic immune escape in MASH-HCC models, informed by the GPR120–FXR/ABCB11–bile acid–NLRC5 axis.
-
Polymyxin B Sulfate: Applied Research Workflows
2026-09-02
Polymyxin B sulfate combines rapid membrane-active antibacterial activity with measurable immune effects, making it useful for Gram-negative bacterial infection research, dendritic cell assays, and carefully controlled microbiome studies. This guide translates those properties into practical workflows while separating product evidence from hypotheses inspired by an allergic-rhinitis reference model.
-
Perospirone and Kv1.5 Channels in Coronary Smooth Muscle
2026-09-01
A 2025 Journal of Applied Toxicology study identifies a previously unrecognized vascular ion-channel action of perospirone: concentration-dependent inhibition of voltage-gated K+ currents in freshly isolated rabbit coronary arterial smooth muscle cells. The findings, including partial pharmacological attribution to Kv1.5 and the absence of use dependence, extend evaluation of this antipsychotic beyond receptor pharmacology and provide a rationale for cardiovascular safety studies.
-
S Tag Peptide: Fusion-Tag Workflow
2026-09-01
S Tag Peptide (SKU A6007) supports recombinant protein detection, antibody-based capture, and protein solubility improvement when genetically fused to a target protein. It should be handled as a soluble peptide reagent or encoded S-peptide fusion tag, not as a standalone enzyme, an independently folded domain, or a material for ethanol-based or long-term aqueous storage.
-
Viral RIPK3 Degradation and Inflammation
2026-08-31
Liu et al. identified a cowpox virus factor that recruits the host SCF machinery to ubiquitinate and degrade RIPK3, thereby inhibiting necroptosis. Genetic comparisons in cells and mice show that this viral inducer of RIPK3 degradation, or vIRD, shapes orthopoxvirus replication, inflammation, and disease severity through the RIPK3–MLKL axis.
-
KX2-391 Dihydrochloride Assay Workflows
2026-08-31
KX2-391 dihydrochloride combines non-ATP-competitive Src inhibition with disruption of tubulin polymerization, enabling integrated oncology, HPV, HBV, and neurotoxin studies. This practical guide converts those mechanisms into concentration-aware workflows, pathway readouts, and troubleshooting decisions.
-
AZD1390 and Replication-Stress Assay Design
2026-08-30
Explore how AZD1390, a selective ATM kinase inhibitor, can be used to interpret G-quadruplex-associated replication stress, DNA damage signaling, and glioblastoma radiosensitization through mechanism-guided assay design.
-
Grazoprevir Hydrate: From Target to Assay
2026-08-29
Grazoprevir hydrate is examined here through a translational lens that connects NS3/4A biology, genotype-aware assay design, pharmacokinetics, and clinical evidence. Learn how to convert antiviral potency data into defensible experimental decisions without confusing in vitro activity with clinical dosing.
-
Nelfinavir Mesylate for Reliable Cell Assays
2026-08-28
This scenario-based guide shows how Nelfinavir Mesylate, SKU A3653, can support reproducible HIV-1 protease inhibition and cell-viability workflows. It connects concentration design, solvent compatibility, interpretation, and ferroptosis research while distinguishing product specifications from hypotheses that require independent validation.
-
Grazoprevir Hydrate: From Potency to Proof
2026-08-28
Grazoprevir hydrate is examined as a research bridge between molecular HCV NS3/4A inhibition and regimen-level evidence. This article explains how genotype, resistance, pharmacokinetics, and patient context should shape interpretation of antiviral data.
-
Degarelix acetate in Hormone Suppression Assays
2026-08-27
Degarelix acetate provides a direct, selective way to suppress GnRH signaling and model downstream LH, FSH, and testosterone changes without the agonist-associated surge. This guide translates its pharmacology into practical receptor-binding, pituitary, prostate cancer, and translational workflows, with assay controls and troubleshooting strategies.
-
SGI-1027 DNA Methyltransferase Inhibitor Workflows
2026-08-27
SGI-1027 combines direct DNMT inhibition with a distinctive lysosomal cell-death phenotype, making it useful for integrated methylation, gene-reactivation, and renal cancer assays. This practical guide covers compound handling, concentration design, combination testing with everolimus, and interpretation of vacuolation, apoptosis, and pyroptosis.